AC
TMO icon

Annandale Capital’s Thermo Fisher Scientific TMO Stock Holding History

Annandale Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19M Buy
4,452
+1,004
+29% +$545K 0.31% 60
2025
Q4 		$2M Hold
3,448
– – 0.24% 65
2025
Q3 		$16.7M Buy
3,448
+1,121
+48% +$522K 0.28% 63
2025
Q2 		$944K Buy
+2,327
New +$973K 0.07% 76

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Annandale Capital's TMO Position: Q1 2026 in Review

Annandale Capital increased its Thermo Fisher Scientific (TMO) stake by 29% in Q1 2026, buying an estimated $545K and bringing the position to 4,452 shares worth $2.19M. The position accounts for 0.31% of the portfolio, ranked #60.

Annandale Capital first reported a position in TMO in Q2 2025 and has held it in 4 quarters since. The position peaked at $16.7M in Q3 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Annandale Capital held 4,452 shares of Thermo Fisher Scientific worth $2.19M as of Q1 2026.
  • Annandale Capital bought 1,004 Thermo Fisher Scientific shares in Q1 2026, an estimated $545K.
  • Thermo Fisher Scientific made up 0.31% of Annandale Capital's portfolio in Q1 2026, its #60 holding.
  • Annandale Capital first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 4 quarters since.
  • Annandale Capital's Thermo Fisher Scientific position peaked at $16.7M in Q3 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Annandale Capital's 13F filing for Q1 2026, filed 15 May 2026.